2
Clinical Trials associated with Umbilical Cord Mesenchymal Stem Cell(Fuzhou General Hospital)Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease: A Randomized Controlled Clinical Trial
Stem cell transplantation has emerged as a relatively popular treatment that can help to regulate immunity, repair injury, and control inflammation. Several studies have used autologous stem cells or adipose-derived stem cells to treat Crohn's disease and its associated complications, and have achieved good efficacy. Thus far, the use of umbilical cord mesenchymal stem cells (UC-MSCs) to treat Crohn's disease has rarely been reported. In this study, UC-MSCs were used to treat patients with hormone-controlled Crohn's disease. We observed the disease control conditions, corticosteroid dosage changes, and treatment-related adverse reactions.
/ Unknown statusEarly Phase 1IIT Mesenchymal Stem Cell Transplantation in the Treatment of Osteonecrosis of the Femoral Head
Mesenchymal Stem Cells (MSCs) have been shown to have immunosuppressive and repairing properties. Bone marrow mononuclear cells (BMMNCs) have revascularization properties and complimentary effects to MSCs. The investigators will infuse expanded autologous MSCs and BMMNCs into patients with osteonecrosis of the femoral head. The study purpose is to examine whether this treatment will result in improvement in osteonecrosis of the femoral head.
100 Clinical Results associated with Umbilical Cord Mesenchymal Stem Cell(Fuzhou General Hospital)
100 Translational Medicine associated with Umbilical Cord Mesenchymal Stem Cell(Fuzhou General Hospital)
100 Patents (Medical) associated with Umbilical Cord Mesenchymal Stem Cell(Fuzhou General Hospital)
100 Deals associated with Umbilical Cord Mesenchymal Stem Cell(Fuzhou General Hospital)